Showing results (181-190 of 281) with videos related to
Sort By:
Pageof 29
Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.Leukemia|August 11, 1998
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemiaJ E Rubnitz, M V Relling, P L Harrison, et al.British Journal of Cancer|January 1, 1997
Mutations at codon 974 of the DPYD gene are a rare eventS A Ridge, O Brown, J McMurrough, et al.British Journal of Cancer|December 1, 1996
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022H L McLeod, V G Brunton, N Eckardt, et al.Cancer Research|November 21, 1998
Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitorsP H Rooney, D A Stevenson, S Marsh, et al.Pharmacogenetics|May 8, 2001
Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in JapaneseK Kumagai, K Hiyama, S Ishioka, et al.Clinical Pharmacology and Therapeutics|October 29, 2010
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemiaN Pottier, S W Paugh, C Ding, et al.Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaJ G Blanco, T Dervieux, M J Edick, et al.Clinical Pharmacology and Therapeutics|January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.The Pharmacogenomics Journal|January 17, 2007
Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancerS Marsh, G Somlo, X Li, et al.Pageof 29